Products

Alismatis Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions

    • Product Name: Alismatis Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions
    • Alias: alismatis-rhizoma-veterinary-grade-api-tablets-injections-capsules-powders-granules-premix-solutions
    • Einecs: 93572-97-1
    • Mininmum Order: 1 g
    • Factroy Site: Yudu County, Ganzhou, Jiangxi, China
    • Price Inquiry: admin@ascent-chem.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    Specifications

    HS Code

    479669

    Product Name Alismatis Rhizoma Veterinary Grade API
    Function Herbal ingredient for veterinary pharmaceuticals
    Dosage Forms Tablets, Injections, Capsules, Powders, Granules, Premix, Solutions
    Appearance Light brown to yellowish powder
    Main Component Alisma orientale (rhizome extract)
    Purity ≥98% (varies by specification)
    Solubility Partially soluble in water and ethanol
    Intended Animals Livestock, poultry, pets
    Storage Conditions Store in cool, dry place away from light
    Shelf Life 24 to 36 months
    Cas Number 73049-73-7
    Country Of Origin China
    Standard Compliance Veterinary pharmacopeias or manufacturer specs

    As an accredited Alismatis Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Secure, sealed 25 kg fiber drum with inner double-layer plastic bags; labeled for Alismatis Rhizoma Veterinary Grade API; batch and expiry details.
    Shipping Alismatis Rhizoma Veterinary Grade API is securely packaged in sealed, moisture-resistant containers to preserve quality during transit. The product is shipped via air or sea freight, compliant with international chemical transport regulations. Temperature and handling protocols ensure safety and product integrity from dispatch to delivery for various pharmaceutical applications.
    Storage Store *Alismatis Rhizoma* Veterinary Grade API in a tightly sealed container, protected from light, moisture, and excessive heat. Keep in a cool, dry, and well-ventilated area, ideally at room temperature (15–30°C). Avoid exposure to incompatible substances and ensure the storage area is secure from unauthorized access. Follow local regulatory and safety guidelines for veterinary pharmaceuticals.
    Application of Alismatis Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions

    Applications of Alismatis Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions in Industrial Manufacturing

    As a direct manufacturer of veterinary-grade Alismatis Rhizoma API, we supply raw materials strictly for verifiable pharmaceutical and feed additive downstream sectors. Below, discover detailed industrial applications across authoritative market segments, with process, formulation, compliance, and finished goods insights derived from real client integration.

    1. Livestock Oral Solid Tablet Production (Swine and Bovine Formulations)

    Veterinary medicinal product manufacturers frequently employ Alismatis Rhizoma API in compound oral tablets targeting urinary and metabolic disorders in pigs and cattle. The ingredient enters formulation stages specifically for renal support blends, utilized at a rate dictated by species, indication, and local regulatory documentation. Its implementation demands analytical substantiation at QC and batch levels per GMP for veterinary finished dose manufacturing, including dissolution and uniformity assessment in high-volume mixer and tableting lines. Final SKUs reach the market as prescription or OTC veterinary medicines, carrying approved monograph-based claims.

    Industry compliance standards

    • China Veterinary Pharmacopoeia (2020 Edition)
    • European Pharmacopoeia Monographs for Herbal APIs (Ph. Eur.)
    • Veterinary Drug GMP (China, EU, US equivalent for specific registrations)
    • VICH GL guidelines as applicable for multinational dossiers

    Typical usage ratio

    • 2% to 12% w/w in formulated tablet mass; ratio varies based on composite API scheme, indicated animal species, and target daily dose requirements. Adjustments respond to registration-driven upper limit control per animal weight and administration frequency.

    Downstream process integration

    • Added after initial dry mixing with functional excipients; followed by wet granulation; inclusion stage requires precision dosing to ensure batch uniformity; proceeds through compaction and tablet compression; final bottling includes environmental and microbial control per GMP for veterinary sites.

    Final product types

    • Veterinary prescription tablets (swine)
    • Veterinary over-the-counter renal support tablets (cattle)
    • Combined herbal-chemical tablets for metabolic regulation
    • Multi-component veterinary health management tablets

    2. Injectable Solution Manufacturing for Companion Animal Use

    Animal pharmaceutical companies integrate Alismatis Rhizoma extract as a standardized API in compounded injectable solutions, directed at treating renal edema and fluid retention in dogs and cats. Processing incorporates precise aqueous dissolution and filtration, with strict aseptic handling throughout formulation and vial filling. Rigorous compliance with pharmacopoeial and sterile product regulations underpins downstream use, with solvent composition and pH adjustment closely monitored to maintain biological stability. These ready-to-administer solutions are delivered under veterinary prescription specifically for clinical practice.

    Industry compliance standards

    • China Veterinary Pharmacopoeia injectable monographs
    • Good Manufacturing Practice for Veterinary Drugs (GMP, global variants)
    • USP Chapter <797> standards for sterile compounding
    • Local animal drug registration/approval requirements for injectables

    Typical usage ratio

    • 0.3% to 1.5% w/v of Alismatis Rhizoma extract in aqueous base; concentration finalized by preclinical and toxicological evaluation, sometimes modulated further by companion ingredient load and final drug stability data.

    Downstream process integration

    • Introduced post-autoclaving of base media under laminar flow conditions; precise volumetric dosing via automated liquid handling lines; followed by sterile filtration, aseptic filling into amber glass vials, and terminal steam sterilization; batch sampling includes sterility and pyrogenicity testing per regulatory release criteria.

    Final product types

    • Parenteral veterinary injection solutions (canine and feline)
    • Hospital-use ampoules for veterinary clinics
    • Combination diuretic injectable preparations

    3. Functional Veterinary Premix for Poultry Feed Integrators

    Feed millers incorporate standardized Alismatis Rhizoma API into poultry feed premixes targeted at kidney health and fluid balance improvement, especially for high-density layer and broiler operations. Blending takes place during the micro-ingredient stage, utilizing precision batching to achieve consistent nutrient distribution. Compliance entails adherence to legal additive lists, withdrawal periods, and ingredient declaration, requiring extra traceability documentation. The final premix undergoes rigorous QC including particle size, blend uniformity, and stability tests to affirm batch integrity prior to export or local market entry.

    Industry compliance standards

    • Chinese Feed Additive Standard (NY/T 2762-2015)
    • EU Feed Hygiene Regulation (EC No 183/2005)
    • Good Manufacturing Practice for Feed Additives
    • Local veterinary feed additive registries (as per MOA or EFSA, if applicable)

    Typical usage ratio

    • 0.05% to 0.8% w/w depending on the premix concentration and specific formulation—levels set by species, age, and anticipated intake rates, and may require reduction for egg-poultry under specific withdrawal period requirements.

    Downstream process integration

    • Dispensed during the precision premix micro-ingredient phase of feed manufacturing; high-shear mixers, ribbon blenders, or paddle mixers employed; API homogeneity achieved before macro-ingredient addition; subsequent steps include weighing, bagging, and palletization with full batch traceability.

    Final product types

    • Veterinary health premix for broilers
    • Functional premix for laying hens kidney support
    • Specialty feed blend for breeder flocks

    4. Herbal Capsule and Granule Formulation for Ruminant Health Management Programs

    Veterinary nutraceutical and specialty feed manufacturers utilize Alismatis Rhizoma powder and granular APIs in single- or multi-component capsule products targeting subclinical kidney issues and fluid retention in cattle, sheep, and goats. The production environment demands adherence to herbal GMPs and employs encapsulation and granulation technologies tailored to animal oral bolus or top-dressed powder administration. Quality verification stresses botanical identity and active marker content. Marketed as veterinary nutraceuticals, such capsules and granules must meet ingredient traceability and finished product content uniformity specifications.

    Industry compliance standards

    • Chinese Veterinary Herbal Product GMP
    • ISO 22000:2018 Food Safety Management for Feed Supplements
    • Veterinary Nutritional Product Regulations (labeling and claims control)
    • Feed/Food Additive Administrative Permission pursuant to region (e.g., EU Registration of Additives for Use in Animal Nutrition)

    Typical usage ratio

    • 1% to 6% by weight in finished capsules or granules, depending on formulation complexity and intended daily animal intake; dilution and carrier content may modulate ratio for dosing convenience or gradual release objectives.

    Downstream process integration

    • API blended with excipients and flow agents during dry-mix phase; enters capsule filling or granule extrusion units; encapsulation, banding, or granule spheronization follow; finished goods go through weight uniformity, botanical identification, and stability evaluation as per QA protocols.

    Final product types

    • Ruminant veterinary herbal capsules
    • Chewable granular supplements for cattle and sheep
    • Powder sachets for on-farm administration

    5. Water-Soluble Veterinary Solution for Intensive Aquaculture Operations

    Specialist aquafeed producers and veterinary service companies integrate Alismatis Rhizoma API into water-soluble powder solutions for use in recirculating aquaculture systems, targeting fish kidney and osmoregulation management under intensive grow-out conditions. The material’s high solubility profile facilitates rapid dispersion and uniform therapeutic concentrations throughout aquatic environments. Formulation must comply with local aquatic animal drug lists and withdrawal intervals, necessitating analytical verification for residue and environmental impact.

    Industry compliance standards

    • Chinese Aquatic Animal Drug Safety Regulations
    • FAO Codex Alimentarius Guidelines for Fish Health Products
    • Fish Veterinary Product GMP (as applicable for region)
    • Residue Monitoring and Withdrawal Protocols (MOA/FAO/WHO)

    Typical usage ratio

    • 0.02% to 0.15% (200-1500mg/liter) in prepared solution or direct tank application; dosing reflects biomass, stocking density, and water turnover rates, with careful titration for continuous administration periods.

    Downstream process integration

    • API blended and solubilized on-site or at factory under controlled conditions; batch-tested for dispersion and solubility; dosing equipment calibrated at fish farm for consistent delivery; periodic water quality and residue testing forms part of production QC.

    Final product types

    • Ready-to-use water-soluble powder sachets for aquaculture
    • Aqueous veterinary solution concentrates for fish tanks
    • Adjunct functional health water treatments for commercial grow-out facilities

    Free Quote

    Competitive Alismatis Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615365186327

    Email: admin@ascent-chem.com

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Alismatis Rhizoma Veterinary Grade API: Elevating Livestock Care

    From Root to Reliable Ingredient: Our Approach

    Our journey with Alismatis Rhizoma began years ago, working directly with producers in the heart of the regions known for their premium Zexie. Walking the muddy fields, inspecting rhizome harvests, and sitting with farmers over simple meals, we learned that consistency in raw material determines everything that follows. It’s not just about cultivation—it’s about knowing which plot produced richer saponin profiles last season, or which farmer’s crop dries most evenly before inspection. Where veterinary health counts on repeatedly safe and active ingredients, these details do not just matter—they shape outcomes for animals and the livelihoods of people who care for them.

    We process Alismatis Rhizoma straight from freshly harvested rhizomes using our closed-loop extraction and refining system. Each batch enters a series of steps: thorough washing and size grading, optimized slicing for uniform exposure, careful dehydration at controlled temperatures to lock in core actives, and gentle powdering designed to preserve the essential triterpenes and polysaccharides. Tests run in our in-house laboratory after each step check for residues, moisture control, and the signature markers you’d expect to see if you’ve handled real, unadulterated Zexie. A dedicated team with years of hands-on extraction work guides the process by experience, not just by protocol printouts or batch numbers.

    Meeting Real-World Veterinary Challenges

    In veterinary medicine, especially among livestock, reliability means more than passing an assay. Diuretic and anti-inflammatory qualities of Alismatis Rhizoma matter to hundreds of farmers who need to clear water retention or support kidney function in swine, poultry, and cattle—without unexpected side effects or unknown adulterants. Delivering an ingredient that performs identically season after season requires more than following the monograph: it asks for vigilance, transparency, and direct accountability.

    Our Veterinary Grade API carries these standards into finished dosage forms: tablets, injections, capsules, powders, granules, premixes, and solutions. Each model, from direct compaction powder to high-purity injectable grade, arises from the same core extract, refined further according to the delivery route’s needs. We’ve worked with veterinarians who faced difficulties adjusting dosages due to shifting extract concentrations; our response focused on refining chromatographic fingerprinting and adding further layers of HPLC validation. Every shipment leaves our facility with full traceability documentation and a complete spectrum analysis, not just a paper certificate.

    Why Structure and Grade Make a Difference

    We manufacture for those who must formulate stable products in varied climates—measured heat zones, sudden humidity spikes, lengthy storage transit times. Tablets, capsules, and powders derived from our API display excellent flow and compressibility because of how we handle particle size. Consistent particle range frees up formulation options, letting clients adjust excipient loads with real control. Veterinary injectables, in particular, require a clear, biocompatible matrix, and demands from this sector nudged us early to fine-tune our last-filtration steps and pyrogen-testing regime.

    API for granules and premixes offers larger granulation support—critical when blending with other active compounds or with sensitive additives like vitamins prone to heat or oxidative breakdown. Clients have reported less stratification and loss during their blending or subsequent bagging lines since switching to our bulk-grade Alismatis. With solutions destined for oral dosing or waterline supplementation, every liter is clarity-tested and free from particulate load or residual odor, allowing for easier administration without risking sediment or clumping in water-dosed feeders.

    Specifying for Applications: What Experience Teaches

    An animal feed company in the south used to face complaints about uneven mixing and dust losses from their premix line. Our team visited, analyzed their entire process from intake silos to final blending, and compared samples side by side. By modifying the granulometry of our Veterinary Grade API and adding a particular moisture conditioning step just before final packing, their throughput improved, and those dusting issues dropped. They now use this grade across multiple lines—one modification leading to smoother runs and better worker safety.

    Veterinarians serving commercial aquaculture operations in the coastal provinces once voiced frustration about cloudiness in injectable Alismatis-based products. Their feedback prompted a six-month cycle of clarifying protocol design and reinvestment in a new filtration system. The difference now shows in solution transparency, and field testing indicates an absence of pyrogenic reactions in large sample cohorts. These cases underscore something textbook guides rarely mention: real-world field applications teach the most, and our flexibility as manufacturers—shape, size, solubility, oxidant sensitivity—directly follows from working closely with those who administer and monitor the products daily.

    How Our Product Stands Out from the Rest

    Plenty of providers source broad-spectrum herbal extracts and push them onto the market. It’s another matter to control for identity markers, pesticides, fungal spores, and heavy metals at every batch. Many third-party traders blend extracts from multiple sources, muddying fingerprints and complicating efforts to trace a problem back to its source. We work only from traceable raw material lots and keep extract lines segregated by batch through full production. Cross-contamination, batch-mixing, and dilution never enter the equation.

    Several veterinary formulation houses in the industry have tried switching suppliers to cut costs, only to see fluctuations in saponin or triterpenoid delivery interrupt their consistent product release. Fluctuating APIs mean more recalls, weaker trust from customers, and a longer path to regaining clinical confidence. We back our API with a standing offer: any client can request parallel batch tests, visit our site, or send in their own auditors—because nothing replaces direct knowledge of the process.

    Unlike generic herbal extracts, each delivery form gets its own process tweak. Tablets and capsules benefit from micronization and dryflow improvement, which means automated presses run cleaner and require fewer rejections. Powders are tailored to resist caking and minimize static charge, resulting in long-term stability in finished feed bags. Injectable and solution forms boast absolute clarification and low endotoxin count, hallmarks confirmed by veterinary pharmacologists during field audits and licensure runs.

    Real Impact in Veterinary Use

    Clients have turned to Alismatis Rhizoma extract to help with a range of veterinary conditions, but two stand out in our records: management of urinary stones in fattening swine and adjuvant treatment of bloat in cattle. We receive regular feedback from field veterinarians monitoring animal response. Those working with consistent dosage forms—using our API—report predictability in clinical signs and a marked drop in incidence once administration protocols stabilize. As one vet pointed out, the difference between a reliable batch and an inconsistent one shows clearest during stressful transitions in large herds: animals respond better, complications decrease, and outcomes become repeatedly documented.

    Feed mill operators have reported less down-time for line cleaning and less material loss during both cold and humid months. This comes down to predictable powder behavior, good solubility in carrier blends, and stability during storage. Improper extraction temperatures or particle mishandling cause issues that show up in final feed consignment—visible caking, off-odors, uneven dosing. By running every production lot through dual-stage environmental simulation, we anticipate these problems and address them before shipment. Direct feedback from front-line users has shaped every design improvement—the closer we listen, the fewer surprises once the product ships out.

    Manufacturing Accountability in Practice

    Being an actual manufacturer holds a different set of responsibilities than acting as a distributor or copywriter. Clients call us not just to report a problem, but to ask for a fix—often urgently. We calibrate our batch processes to take into account the exact veterinary use-case: oral, IM, IV, or feed inclusion. Each presents different handling requirements and, accordingly, different tolerances for moisture, flow, and microbial load. Our onsite team samples in progress, makes micro-adjustments on the fly, and can rerun a portion of a lot if any reading deviates.

    Investing in robust batch recording—down to the sourcing farm, test results per drum, validated cleaning logs—lets us respond quickly to trace-back audits or field inquiries. This detailed recordkeeping deters shortcutting and reinforces the habits that prevent future problems. Every year, we open our doors to technical partners, veterinary regulators, and end-users for process walk-throughs. The transparency keeps standards high because accountability is visible and direct.

    Adapting to Changing Demands and Regulation

    In the current regulatory landscape, animal health authorities demand tighter documentation and clearer evidence linking batches to outcomes. Our protocols evolve to stay ahead—not just reacting to requirements, but anticipating where future reforms will focus. For example, increased concerns about antibiotic residue and the shift towards phytogenic animal health solutions have prompted many feed integrators to review all botanical APIs with a finer lens.

    We’ve expanded pesticide screening, not just on harvested rhizomes but on finished API. Multiresidue GC-MS panels pick up both unlikely contaminants and those that previously fell under the reporting radar. Heavy metal and mycotoxin checks get repeated at more points—both entry and prepack. We proactively engage clients to learn what hurdles their QA teams face each season and adjust our release criteria accordingly. This hands-on approach responds to market realities before they escalate into logistical or regulatory bottlenecks.

    Veterinary input in feed and medication continues evolving; shifts in animal genetics, new pathogens, and global climate instability present variables every year. Clients seeking to replace or reduce synthetic inputs require assurance their herbal APIs do more than hit basic markers—they must integrate seamlessly in complex rations, dissolve uniformly, and maintain substance during storage spikes. By forward-integrating technical feedback from veterinary trials into processing design, we keep our offerings practical under the widest possible range of conditions.

    Feedback Streams: Clients as Partners, Not Just Customers

    Every package shipped is backed by two-way information flow. Our technical support team—composed of chemists who run the plant, not just sales reps—handles client reports, suggests minor formulation tweaks, and often heads out to visit with end users experiencing an issue. In the field, nothing replaces eyes-on insight. For example, a poultry operation in an arid zone experienced rapid settling and dosing variation upon switching to a new transport vehicle. After review, a minor moisture correction at our end led to marked improvement in flow behavior and downstream efficacy.

    Often, we receive feedback not as criticism but as a chance to solve something novel—a new disease outbreak, local water chemistry variation, or a spike of unstable barn humidity. We bring reported sample deviations back for in-facility cross-checking. Where a fix is beyond tweakable process parameters, we incorporate findings into the next production design cycle. Clients remain partners in an ongoing cycle of product iteration, which drives the broader adaptability that regulatory or copycat competitors can’t match.

    Working Toward Sustainable, Value-Focused Veterinary Manufacturing

    Sourcing Alismatis Rhizoma for the veterinary sector often faces tension between modern demand, climate-driven crop reduction, and long-term field health. We interact directly with our grower base, offering incentives for crop rotation and sustainable pesticide choices. Ensuring a strong supply for veterinary applications links directly to better field income at the primary level—growers willing to wait for full-maturity crops that deliver superior extract profiles, earning better contracts tied to our tested results.

    Each time raw material prices surge or harvest windows shrink due to weather, manufacturers have tough choices: dilute, blend, or refuse substandard lots. Unlike traders, we have held back on entering speculative spot markets with lesser material. Each failed batch affects clients’ trust and animal lives downstream. This approach means holding inventory longer and being selective with contracts—but it keeps our quality dependable.

    Efforts also extend to environmental footprints at our processing facility. Closed-loop water use, low-energy drying, and comprehensive waste recovery programs run daily. We examine the carbon and chemical burdens at every processing stage, knowing that the global veterinary industry faces increasing pressure to report and actively reduce environmental impacts. Each advance in processing efficiency follows from our ongoing sustainability review, not just as a checkbox for outside auditors, but as a practical step to secure future raw material consistency and client trust.

    Looking Ahead: Steady Value in Veterinary-Grade Alismatis Rhizoma API

    Decades in botanical ingredient production for animal health have highlighted critical lessons: no substitution exists for direct accountability, and improvements in process flow and product form always pay back in animal welfare gains and customer retention. The difference between an average and a great product is most visible in field results—consistent animal recoveries, easier formulation, true-to-claim actives.

    We approach Alismatis Rhizoma Veterinary Grade API not as an interchangeable commodity, but as a living ingredient shaped by soil, climate, season, and the direct actions of all hands in our supply chain. Our commitment to producing only veterinary-suitable batches extends to every step of manufacturing, and every lot we release is a result of years of accumulated expertise and a standing willingness to revisit, refine, and adapt as both regulatory and practical demands evolve.

    The veterinary sector deserves clarity about where their ingredients come from, how they are made, and whether they will work on real farms with living animals. We keep our offerings focused, verifiable, and responsive to decades of feedback and experience. The next time your team faces a challenge in veterinary formulation—be it powder flow, tablet hardness, solution clarity, or simply sourcing a true-to-type extract—know that at the level of manufacturing, there’s a difference. We make it our responsibility to ensure it stays that way.

    Top